Gilnei B da Silva, Daiane Manica, Alana P da Silva, Eduarda Valcarenghi, Sabine R Donassolo, Greicy C Kosvoski, Maiqueli E D Mingoti, Jullye Gavioli, Joana V Cassol, Marceli C Hanauer, Mariélly B Hellmann, Filomena Marafon, Amanda G Bertollo, Jesiel de Medeiros, Arthur D Cortez, Gislaine Z Réus, Gabriela G de Oliveira, Zuleide M Ignácio, Margarete D Bagatini
We evaluated glycemia and triglyceride, hepatic, muscular, and renal damage markers, redox profile, and leptin and ghrelin hormone levels of COVID-19 patients. We also realized statistical analysis to verify the potential of biomarkers to predict poor prognosis and the correlation between them in severe cases. We assessed glycemia and the levels of triglycerides, hepatic, muscular, and renal markers in automatized biochemical analyzer. The leptin and ghrelin hormones were assessed by the ELISA assay. Severe cases presented high glycemia and triglyceride levels...
April 16, 2024: American Journal of the Medical Sciences